Changes in the Pneumococcal Vaccination Uptake and Its Determinants before, during, and after the COVID-19 Pandemic among Community-Living Older Adults in Hong Kong, China: Repeated Random Telephone Surveys.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
    • Publication Information:
      Original Publication: Basel, Switzerland : MDPI AG
    • Abstract:
      Pneumococcal vaccination (PV) is effective in preventing vaccine-type pneumococcal diseases. This study investigated the changes in PV uptake and its determinants before, during, and after the Coronavirus Disease 2019 (COVID-19) pandemic among community-living older adults aged ≥65 years in Hong Kong, China. Three rounds of random telephone surveys were conducted every two years from May 2019 to October 2023. Multivariate logistic regression models were fitted to examine the between-round differences in PV uptake rate and factors associated with PV uptake in each round. This study included 1563 participants. The standardized PV uptake rate in Round 1, 2, and 3 was 17.3%, 28.3%, and 35.5%, respectively. A significant difference in the PV uptake rate was found between Rounds 2 and 1 ( p = 0.02), but not between Rounds 3 and 2 ( p = 0.98). Perceived barriers, cue to action and self-efficacy, were significant determinants of PV uptake in all rounds. Perceived benefits were significant determinants of PV uptake in the first and second rounds, but not in the third round. Continuous monitoring of PV uptake and its determinants, and evaluating and adjusting the PV program, might contribute to the success of such a vaccination program in the post-pandemic era.
    • References:
      J Infect Dis. 2022 Mar 2;225(5):836-845. (PMID: 34537847)
      BMC Infect Dis. 2016 Sep 26;16(1):515. (PMID: 27670446)
      Int J Health Policy Manag. 2022 Apr 01;11(4):508-513. (PMID: 33105965)
      Vaccine. 2022 Jul 30;40(32):4380-4393. (PMID: 35781171)
      Vaccines (Basel). 2021 Mar 03;9(3):. (PMID: 33802327)
      Vaccine. 2019 May 9;37(21):2797-2804. (PMID: 31005428)
      Hum Vaccin Immunother. 2018 Feb 1;14(2):430-441. (PMID: 29194019)
      Hum Vaccin Immunother. 2021 Feb 1;17(2):527-536. (PMID: 32614636)
      Vaccines (Basel). 2021 Dec 20;9(12):. (PMID: 34960253)
      Vaccines (Basel). 2023 May 04;11(5):. (PMID: 37243046)
      PLoS One. 2021 May 24;16(5):e0251963. (PMID: 34029345)
      Vaccine. 2020 Oct 21;38(45):7146-7155. (PMID: 32943265)
      Vaccine. 2021 Nov 16;39(47):6883-6893. (PMID: 34711437)
      Vaccines (Basel). 2022 Sep 02;10(9):. (PMID: 36146530)
      Health Educ Res. 2011 Apr;26(2):308-22. (PMID: 21321008)
      Public Health. 2018 Mar;156:67-78. (PMID: 29408191)
      Front Immunol. 2022 Mar 10;13:839433. (PMID: 35359948)
      Epidemiol Infect. 2011 May;139(5):666-73. (PMID: 20696084)
      Vaccine. 2021 Dec 17;39(51):7494-7502. (PMID: 34839993)
      BMC Public Health. 2014 May 12;14:442. (PMID: 24884433)
      Diagnostics (Basel). 2022 Dec 07;12(12):. (PMID: 36553093)
      Vaccines (Basel). 2021 Jun 25;9(7):. (PMID: 34202016)
    • Grant Information:
      20190972 Health and Medical Research Fund, Food and Health Bureau, Hong Kong Special Administration Region of China
    • Contributed Indexing:
      Keywords: COVID-19; community-living older adults; health belief model; pneumococcal vaccination; random telephone survey
    • Publication Date:
      Date Created: 20240829 Latest Revision: 20240901
    • Publication Date:
      20240902
    • Accession Number:
      PMC11359888
    • Accession Number:
      10.3390/vaccines12080894
    • Accession Number:
      39204020